This month PAC Partners initiated analyst coverage on Anatara Lifesciences.
PAC has initiated coverage with a Buy rating and price target of $1.36/share.
To download the full report, please click here.
This month PAC Partners initiated analyst coverage on Anatara Lifesciences.
PAC has initiated coverage with a Buy rating and price target of $1.36/share.
To download the full report, please click here.